Description

5H-Cyclopenta[D]Pyrazolo[1,5-A]Pyrimidine-2-Carboxamide,6,7-Dihydro-n-(5-Methyl-1,3,4-Thiadiazol-2-Yl)-8-(Trifluoromethyl)-(9Ci) CAS NO 606096-56-4 is a high-purity, advanced pharmaceutical intermediate characterized by a complex fused heterocyclic structure. This compound is a critical building block in modern medicinal chemistry, enabling the synthesis of novel active pharmaceutical ingredients (APIs) with targeted therapeutic effects. It is primarily required by research institutions and pharmaceutical manufacturers engaged in the development of new drugs, particularly in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• API Development: Integral in the multi-step synthesis of complex Active Pharmaceutical Ingredients (APIs), especially those containing pyrazolo-pyrimidine motifs.
• Biochemical Tool Compound: May be utilized in biochemical assays to study enzyme inhibition or receptor binding mechanisms.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.

Basic Information

Item	Detail
Product Name	5H-Cyclopenta[D]Pyrazolo[1,5-A]Pyrimidine-2-Carboxamide,6,7-Dihydro-n-(5-Methyl-1,3,4-Thiadiazol-2-Yl)-8-(Trifluoromethyl)-(9Ci)
CAS No.	606096-56-4
Molecular Formula	C14H11F3N6OS
Molecular Weight	368.34 g/mol
Synonyms	6,7-Dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide; 5H-Cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxamide, 6,7-dihydro-N-(5-methyl-1,3,4-thiadiazol-2-yl)-8-(trifluoromethyl)-; CAS 606096-56-4; 606096-56-4; 8-(Trifluoromethyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine-2-carboxylic acid (5-methyl-1,3,4-thiadiazol-2-yl)amide
EINECS	Contact for details

Quality Control

Our 5H-Cyclopenta[D]Pyrazolo[1,5-A]Pyrimidine-2-Carboxamide intermediate is produced under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) with detailed chromatographic data and spectral information are provided for full traceability and regulatory support.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (NMR)	Conforms
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.